INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

72,535 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
NS
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
MGTXMeiraGTx Holdings plc
Open-market sale · 10b5-1 plan
SELL$294K
27.7K sh
Oct 6, 2026Oct 6, 2026
Page 281 of 1814
← PrevNext →
traded Oct 6, 2026
+0d
SEC Form 4

Evidence

12
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Tax withholding
F$824K
13.4K sh
Oct 3, 2026Oct 6, 2026
traded Oct 3, 2026
+3dSEC Form 4

Evidence

11
OM
Orlando MatthewGeneral Counsel
KVUEKenvue Inc.
Grant or award
A$615K
35.8K sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
BA
Bruno Marc ACOO, U.S. Food & Facilities
ARMKAramark
Tax withholding
F$744K
13.6K sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
GE
Gal EidoDirector, Chief Executive Officer, 10% Owner
RSKDRISKIFIED LTD.
Tax withholding
F$273K
34.4K sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

11
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$17K
797 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
1,797 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
3,008 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.03M
21.0K sh
Oct 6, 2026Oct 6, 2026
traded Oct 6, 2026
+0dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$172K
2,492 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$12K
558 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

11
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
800 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

11
DA
Dotcheva AglikaChief Financial Officer
RSKDRISKIFIED LTD.
Tax withholding
F$480K
60.5K sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

10
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Grant or award
A—
41.2K sh
Oct 3, 2026Oct 6, 2026
traded Oct 3, 2026
+3dSEC Form 4

Evidence

10
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Grant or award
A—
30.9K sh
Oct 3, 2026Oct 6, 2026
traded Oct 3, 2026
+3dSEC Form 4

Evidence

10
AL
Alpern Paul LVP and General Counsel
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
6,003 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

9
WS
Wilder Ben SimonChief Operating Officer
ARQQArqit Quantum Inc.
Option exercise
M—
167 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Option exercise
M—
17 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
LM
Lefebvre d'Ovidio ManfrediDirector
ARQQArqit Quantum Inc.
Option exercise
M—
83 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
LM
Lefebvre d'Ovidio ManfrediDirector
ARQQArqit Quantum Inc.
Option exercise
M—
67 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
LS
Lee Hoan SooDirector, Chief Executive Officer
XLABExascale Labs Holdings Inc.
Grant or award
A—
300.0K sh
Oct 6, 2026Oct 6, 2026
traded Oct 6, 2026
+0dSEC Form 4

Evidence

9
GR
Globokar Brian R.SVP, Dr of Trust & Wealth Mgmt
HBIA.PKHILLS BANCORPORATION
Grant or award
A$2,250
56 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
SK
Sidow Kevin K.Director
SISHOULDER INNOVATIONS, INC.
Grant or award
A$17K
892 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

9
LA
Leaver AndrewChief Executive Officer
ARQQArqit Quantum Inc.
Option exercise
M—
5,208 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
SA
Shileny Lisa ADirector, President and CEO
HBIA.PKHILLS BANCORPORATION
Grant or award
A$2,250
56 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
CC
Calabria CarloDirector
ARQQArqit Quantum Inc.
Option exercise
M—
17 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
LM
Lefebvre d'Ovidio ManfrediDirector
ARQQArqit Quantum Inc.
Option exercise
M—
17 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
LM
Lefebvre d'Ovidio ManfrediDirector
ARQQArqit Quantum Inc.
Option exercise
M—
83 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
CC
Calabria CarloDirector
ARQQArqit Quantum Inc.
Option exercise
M—
83 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
FP
Feenan PaulChief Revenue Officer
ARQQArqit Quantum Inc.
Option exercise
M—
322 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A$28K
140 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

9
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Derivative conversion · 10b5-1 plan
C$4.87M
500.0K sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC Form 4

Evidence

9
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Option exercise
M—
83 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Option exercise
M—
17 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
CC
Calabria CarloDirector
ARQQArqit Quantum Inc.
Option exercise
M—
67 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
LM
Lefebvre d'Ovidio ManfrediDirector
ARQQArqit Quantum Inc.
Option exercise
M—
83 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
WP
Willcocks PatrickGeneral Counsel
ARQQArqit Quantum Inc.
Option exercise
M—
305 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
CC
Calabria CarloDirector
ARQQArqit Quantum Inc.
Option exercise
M—
83 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence

9
JB
Johnson BlakeChief Financial Officer
GPMTGranite Point Mortgage Trust Inc.
Option exercise
M—
22.1K sh
Oct 4, 2026Oct 6, 2026
traded Oct 4, 2026
+2dSEC Form 4

Evidence

9
VM
VanHimbergen Robert MEVP and CFO
ELANElanco Animal Health Inc
Grant or award
A$197
9 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC Form 4

Evidence